These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
669 related items for PubMed ID: 30745542
1. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient. Sasaki T, Nakamura K, Naito S. Int Heart J; 2019 Mar 20; 60(2):466-469. PubMed ID: 30745542 [Abstract] [Full Text] [Related]
2. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience. Weinstock J, Bader YH, Maron MS, Rowin EJ, Link MS. J Am Heart Assoc; 2016 Feb 12; 5(2):. PubMed ID: 26873684 [Abstract] [Full Text] [Related]
3. Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end. Noel A, Ploux S, Bulliard S, Strik M, Haeberlin A, Welte N, Marchand H, Klotz N, Ritter P, Haïssaguerre M, Bordachar P. Heart Rhythm; 2020 Jan 12; 17(1):66-74. PubMed ID: 31295585 [Abstract] [Full Text] [Related]
6. Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD. Corzani A, Ziacchi M, Biffi M, Diemberger I, Martignani C, Boriani G. Indian Heart J; 2015 Jan 12; 67(1):56-9. PubMed ID: 25820052 [Abstract] [Full Text] [Related]
14. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management. Kooiman KM, Knops RE, Olde Nordkamp L, Wilde AA, de Groot JR. Heart Rhythm; 2014 Mar 12; 11(3):426-34. PubMed ID: 24321235 [Abstract] [Full Text] [Related]
17. Inappropriate discharges from an intravenous implantable cardioverter defibrillator due to T-wave oversensing. Washizuka T, Chinushi M, Kasai H, Watanabe H, Tagawa M, Hosaka Y, Abe A, Aizawa Y. Jpn Circ J; 2001 Jul 12; 65(7):685-7. PubMed ID: 11446507 [Abstract] [Full Text] [Related]
18. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Roses-Noguer F, Jarman JW, Clague JR, Till J. Heart Rhythm; 2014 Jan 12; 11(1):58-66. PubMed ID: 24120999 [Abstract] [Full Text] [Related]
19. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, Arora R, Chicos AB, Kim SS, Lin AC, Passman RS, Knight BP. Heart Rhythm; 2014 Aug 12; 11(8):1361-6. PubMed ID: 24755323 [Abstract] [Full Text] [Related]